55.09 USD
+1.1 (+2.04%)
55.08 USD
-0.01 (-0.02%)
MDLZ gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 87 industry peers in the Food Products industry. While MDLZ has a great profitability rating, there are some minor concerns on its financial health. MDLZ is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
In the past year MDLZ had a positive cash flow from operations.
Each year in the past 5 years MDLZ has been profitable.
MDLZ had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 4.95%, MDLZ is doing good in the industry, outperforming 74.71% of the companies in the same industry.
MDLZ has a Return On Equity of 13.49%. This is amongst the best in the industry. MDLZ outperforms 82.76% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.25%, MDLZ is in the better half of the industry, outperforming 67.82% of the companies in the same industry.
MDLZ had an Average Return On Invested Capital over the past 3 years of 7.83%. This is significantly below the industry average of 27.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROIC | 6.25% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
Looking at the Profit Margin, with a value of 9.38%, MDLZ belongs to the top of the industry, outperforming 87.36% of the companies in the same industry.
In the last couple of years the Profit Margin of MDLZ has declined.
MDLZ has a better Operating Margin (11.59%) than 79.31% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ's Gross Margin of 31.05% is fine compared to the rest of the industry. MDLZ outperforms 70.11% of its industry peers.
In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDLZ is still creating some value.
Compared to 1 year ago, MDLZ has less shares outstanding
Compared to 5 years ago, MDLZ has less shares outstanding
Compared to 1 year ago, MDLZ has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.25 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
MDLZ has a Altman-Z score (2.25) which is comparable to the rest of the industry.
MDLZ has a debt to FCF ratio of 9.31. This is a negative value and a sign of low solvency as MDLZ would need 9.31 years to pay back of all of its debts.
MDLZ's Debt to FCF ratio of 9.31 is fine compared to the rest of the industry. MDLZ outperforms 60.92% of its industry peers.
A Debt/Equity ratio of 0.76 indicates that MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio of 0.76. This is comparable to the rest of the industry: MDLZ outperforms 40.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Altman-Z | 2.25 |
ROIC/WACC0.84
WACC7.46%
2.3 Liquidity
A Current Ratio of 0.61 indicates that MDLZ may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.61, MDLZ is doing worse than 88.51% of the companies in the same industry.
A Quick Ratio of 0.37 indicates that MDLZ may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.37, MDLZ is doing worse than 82.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
The earnings per share for MDLZ have decreased strongly by -21.70% in the last year.
MDLZ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.91% yearly.
Looking at the last year, MDLZ shows a small growth in Revenue. The Revenue has grown by 4.13% in the last year.
MDLZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.09% yearly.
EPS 1Y (TTM)-21.7%
EPS 3Y6.45%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
3.2 Future
The Earnings Per Share is expected to grow by 3.92% on average over the next years.
Based on estimates for the next years, MDLZ will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y-14.33%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
EPS Next 5Y3.92%
Revenue Next Year4.87%
Revenue Next 2Y4.39%
Revenue Next 3Y4.16%
Revenue Next 5Y3.83%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.33, the valuation of MDLZ can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as MDLZ.
When comparing the Price/Earnings ratio of MDLZ to the average of the S&P500 Index (27.19), we can say MDLZ is valued slightly cheaper.
With a Price/Forward Earnings ratio of 17.18, MDLZ is valued on the expensive side.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than 63.22% of the companies in the same industry.
MDLZ is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.92, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.33 | ||
| Fwd PE | 17.18 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDLZ is on the same level as its industry peers.
MDLZ's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.04 | ||
| EV/EBITDA | 15.51 |
4.3 Compensation for Growth
MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.8
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.70%, MDLZ has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.47, MDLZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.92, MDLZ pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
5.2 History
On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
MDLZ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
69.92% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
55.09
+1.1 (+2.04%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners89.35%
Inst Owner Change-0.09%
Ins Owners0.15%
Ins Owner Change0%
Market Cap71.09B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts78.24
Price Target69.55 (26.25%)
Short Float %2.46%
Short Ratio3.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-0.75%
PT rev (3m)-7.16%
EPS NQ rev (1m)-0.42%
EPS NQ rev (3m)-15.52%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)-4.16%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-1.65%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.33 | ||
| Fwd PE | 17.18 | ||
| P/S | 1.89 | ||
| P/FCF | 31.04 | ||
| P/OCF | 19.88 | ||
| P/B | 2.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.51 |
EPS(TTM)2.85
EY5.17%
EPS(NY)3.21
Fwd EY5.82%
FCF(TTM)1.77
FCFY3.22%
OCF(TTM)2.77
OCFY5.03%
SpS29.17
BVpS20.29
TBVpS-13.7
PEG (NY)N/A
PEG (5Y)2.8
Graham Number36.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROCE | 8.75% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 45.17% | ||
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% | ||
| FCFM | 6.08% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 96.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 64.85% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 2.25 |
F-Score5
WACC7.46%
ROIC/WACC0.84
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.45%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-14.33%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year4.87%
Revenue Next 2Y4.39%
Revenue Next 3Y4.16%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year6.67%
EBIT Next 3Y6.61%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 5 / 10 to MDLZ.
Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a valuation rating of 3 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Overvalued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for MDLZ stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 19.33 and the Price/Book (PB) ratio is 2.72.
Can you provide the dividend sustainability for MDLZ stock?
The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 69.92%.